kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.41%2.91B | -4.34%11.39B | -7.45%2.88B | -6.50%2.84B | 1.33%11.91B | 2.83B | -0.88%2.93B | 4.15%3.11B | 10.33%3.04B | 18.31%11.75B |
Cost of revenue | -0.14%2.01B | -6.16%8.02B | -9.42%2.02B | -8.70%2.01B | 7.81%8.55B | 2.02B | 4.71%2.1B | 13.40%2.24B | 18.89%2.2B | 24.08%7.93B |
Gross profit | 8.62%898.73M | 0.28%3.37B | -2.43%854.29M | -0.69%827.43M | -12.10%3.36B | 810.31M | -12.55%839.08M | -13.79%875.52M | -7.32%833.16M | 7.90%3.82B |
Operating expense | 14.52%487.45M | 5.20%1.66B | -6.65%377.77M | 17.01%425.64M | 2.04%1.58B | 395.54M | 6.12%415.39M | 8.46%404.7M | 1.36%363.77M | -1.53%1.55B |
Operating profit | 2.36%411.27M | -4.09%1.71B | 1.21%476.51M | -14.40%401.79M | -21.74%1.78B | 414.77M | -25.42%423.69M | -26.72%470.82M | -13.09%469.38M | 15.43%2.27B |
Net non-operating interest income (expenses) | 97.53%-4K | |||||||||
Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.53%4K |
Net investment income | 80.65%-1.93M | 73.35%-2.94M | 426.94%3.33M | -775.64%-9.96M | 36.63%-11.02M | -7.01M | 67.89%-3.5M | 538.19%631K | 70.78%-1.14M | -11,729.25%-17.39M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 40.47%-69.18M | -1,646.20%-2.64M | -62.43M | -3,192.01%-116.21M | -104.28M | -12.1M | 126.23%171K | 0 | 98.37%-3.53M |
Less:Other special charges | ---- | -40.56%69.18M | --2.64M | --62.43M | 3,197.34%116.4M | --104.28M | --12.1M | ---- | ---- | 137.71%3.53M |
Less:Write off | ---- | --0 | ---- | ---- | ---188K | --0 | --0 | ---- | ---- | --0 |
Other non-operating income (expenses) | 37.97%2.78M | -83.13%5.62M | -112.35%-1.25M | -82.53%2.01M | -33.19%33.3M | 4.55M | 231.60%7.15M | -80.67%10.08M | 171.57%11.52M | -16.60%49.85M |
Income before tax | 24.35%412.12M | -2.69%1.64B | -1.20%475.95M | -30.92%331.41M | -26.80%1.68B | 308.04M | -25.76%415.23M | -30.57%481.7M | -9.34%479.76M | 26.99%2.3B |
Income tax | 45.08%166.82M | 27.79%581.66M | -2.33%156.18M | -22.10%114.98M | -25.64%455.16M | 7.44M | -22.86%140.21M | 43.78%159.91M | 1.02%147.6M | -15.65%612.1M |
Net income | 13.34%245.3M | -13.98%1.06B | -0.63%319.76M | -34.84%216.43M | -27.22%1.23B | 300.6M | -27.16%275.02M | -44.77%321.79M | -13.29%332.17M | 55.46%1.69B |
Net income continuous operations | 13.34%245.3M | -13.98%1.06B | -0.63%319.76M | -34.84%216.43M | -27.22%1.23B | --300.6M | -27.16%275.02M | -44.77%321.79M | -13.29%332.17M | 55.46%1.69B |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 13.34%245.3M | -13.98%1.06B | -0.63%319.76M | -34.84%216.43M | -27.22%1.23B | 300.6M | -27.16%275.02M | -44.77%321.79M | -13.29%332.17M | 55.46%1.69B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 13.34%245.3M | -13.98%1.06B | -0.63%319.76M | -34.84%216.43M | -27.22%1.23B | 300.6M | -27.16%275.02M | -44.77%321.79M | -13.29%332.17M | 55.46%1.69B |
Gross dividend payment | ||||||||||
Basic earnings per share | 11.59%21.27 | -24.98%92.08 | -13.28%27.81 | -42.43%19.06 | -27.11%122.74 | 30.08 | -26.97%27.48 | -44.77%32.07 | -13.28%33.11 | 56.72%168.38 |
Diluted earnings per share | 11.59%21.27 | -24.98%92.08 | -13.55%27.7232 | -42.43%19.06 | -27.11%122.74 | 30.08 | -26.97%27.48 | -44.77%32.07 | -13.28%33.11 | 56.72%168.38 |
Dividend per share | 0 | 19.23%31 | 0 | 0 | 8.33%26 | 26 | 0 | 0 | 0 | 71.43%24 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |